【结 构 式】 |
【分子编号】50385 【品名】benzyl [4-(azidomethyl)phenyl](imino)methylcarbamate 【CA登记号】 |
【 分 子 式 】C16H15N5O2 【 分 子 量 】309.3276 【元素组成】C 62.13% H 4.89% N 22.64% O 10.34% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(IV)The reaction of 4-cyanobenzyl bromide (I) with NaN3 in DMF gives 4-cyanobenzyl azide (II), which is treated first with HCl and then with ammonia to yield 4-(azidomethyl)benzamidine (III). Protection of the amidino group of (III) with benzyl chloroformate affords the protected compound (IV), which is finally reduced at the azido group with PPh3 in THF to provide 4-(benzyloxycarbonylamidino)benzylamine (V).
【1】 Bayes, M.; Silvestre, J.S.; Sorbera, L.A.; Castaner, J.; Melagatran and Ximelagatran. Drugs Fut 2001, 26, 12, 1155. |
【2】 Antonsson, K.T.; Bylund, R.E.; Gustafsson, N.D.; Nilsson, N.O.I. (AstraZeneca plc); New peptide derivs.. EP 0701568; JP 1996511018; JP 2001322974; US 5602253; US 5723444; WO 9429336 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14200 | 4-(Bromomethyl)benzonitrile; alpha-Bromo-p-tolunitrile | 17201-43-3 | C8H6BrN | 详情 | 详情 |
(II) | 50383 | 4-(azidomethyl)benzonitrile | C8H6N4 | 详情 | 详情 | |
(III) | 50384 | 4-(azidomethyl)benzenecarboximidamide | C8H9N5 | 详情 | 详情 | |
(IV) | 50385 | benzyl [4-(azidomethyl)phenyl](imino)methylcarbamate | C16H15N5O2 | 详情 | 详情 | |
(V) | 50386 | benzyl [4-(aminomethyl)phenyl](imino)methylcarbamate | C16H17N3O2 | 详情 | 详情 |
Extended Information